Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Colorado Joint Replacement

Status and phase: Enrolling; Phase 4

Conditions: Degenerative Osteoarthritis

Treatments: Drug: Benzoyl peroxide gel

Study type: Interventional

Funder types: Other

Identifiers

NCT03849885

1378012

Details and patient eligibility

About

This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium, more specifically P acnes, the same bacterium that is responsible for the majority of acne. Information affecting hip surgery is currently unknown.

Full description

This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium. The most common bacterium of this family is P acnes, the same bacterium that is responsible for the majority of acne. There is increasing evidence that infection with P acnes and other Propionibacterium is a significant source of failure following certain orthopaedic shoulder procedures. However, information affecting hip surgery is currently unknown. Our personal experience leads us to believe that the numbers are actually quite high, since we are seeing an increased rate of Propionibacterium infection of hip replacement in the community. However, this type of study has never been done before, and therefore we simply do not know an accurate estimate for the average hip replacement patient's risk for Propionibacterium infection following hip replacement.

Enrollment: 496 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients who are 18 to 79 85 years of age
• CJR primary joint arthroplasty patients who are receiving care at Porter Adventist Hospital
• CJR established primary knee or hip arthroplasty patients with a native hip joint (no replacement on the biopsy side) who volunteers as a research participant.
• CJR patients without a previous arthroplasty procedure who have established care with our practice.

Exclusion criteria

• Previous history of hip infection
• Current antibiotic use or antibiotic use within the past week
• Previous history of Cutibacterium joint infection
• Current immunodeficiency disease or disorder
• Patients with active psoriatic disease or other focal inflammation over the hip
• Previous total hip arthroplasty (bilateral for the case of TKA patients and healthy volunteers, contralateral for THA patients)

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

496 participants in 2 patient groups

Standard Skin Prep

No Intervention group

Description:

Patients will undergo a skin cleansing protocols using 4% Chlorhexidine gluconate (CHG) cloths. After the skin prep, three 3-mm punch (Acu-Punch, Acuderm, Fort Lauderdale, FL) skin biopsies will performed for both an anterior-based hypothetical incision, and for a more lateral/posterior incision, for a total of 6 biopsies taken per subject.

Experimental Skin Prep with BPO

Experimental group

Description:

Patients will undergo a skin cleansing protocols using 4% Chlorhexidine gluconate (CHG) cloths. Following the CHG wipes, patients will be prepped with 5% BPO gel applied directly to the biopsy site. After the skin prep, three 3-mm punch (Acu-Punch, Acuderm, Fort Lauderdale, FL) skin biopsies will performed for both an anterior-based hypothetical incision, and for a more lateral/posterior incision, for a total of 6 biopsies taken per subject.

Treatment:

Drug: Benzoyl peroxide gel